2024年5月5日 · Calcium channel blockers restrict the amount of calcium entering cardiac and smooth muscle cells by blocking voltage-gated calcium channels. This causes blood vessels …

Calcium channel blockers (CCB), calcium channel antagonists or calcium antagonists [2] are a group of medications that disrupt the movement of calcium (Ca 2+) through calcium channels. …

2024年2月22日 · Managing CCB-Induced Hypotension. In cases of hypotension, initial treatment with intravenous (IV) fluids requires caution in those with congestive heart failure, pulmonary …

For more than a decade, only one IV dihydropyridine calcium channel blocker (CCB), nicardipine, has been available for IV use for treatment of hypertension.

钙通道阻滞剂 [1] （calcium channel blocker，CCB）又称鈣離子通道阻斷劑 [2] 、鈣通道拮抗劑（calcium channel antagonist、calcium antagonist [3] ），是一类干扰钙离子通过细胞膜上的 …

2017年9月1日 · For intravenous use: Cleviprex is intended for intravenous use. Titrate Cleviprex to achieve the desired blood pressure reduction. Individualize dosage depending on the blood …

Calcium channel blockers (CCBs) are a class of drugs used to treat high blood pressure, angina, abnormal heart rhythms, migraines, pulmonary hypertension, cardiomyopathies, and …

2022年8月18日 · Calcium channel blockers (CCBs) are a class of medications that inhibit voltage-dependent L-type calcium channels of cardiac and vascular smooth muscle cells. The …

The antiarrhythmic properties (Class IV antiarrhythmics) of CCBs are related to their ability to suppress firing of aberrant pacemaker sites within the heart and their ability to decrease …

Intravenous nicardipine hydrochloride is licensed for the treatment of acute life-threatening hypertension, for example in the event of malignant arterial hypertension or hypertensive …